A Randomized, Open-Label, Two-Way Crossover Study to Determine the Effects of Co-Administration of AZD7325 and a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs AZD 7325; Ethinylestradiol/norgestimate
- Indications Anxiety; Pregnancy
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 30 Oct 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 19 May 2009 New trial record